Coronavirus Live Count Map India
remove_red_eye 581 Views
Coronavirus Live Count Map World
#Diabetes and Endocrinology #Internal Medicine #Pharmacist
Coronavirus FAQ PDF
Sodium glucose cotransporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes appear to be as safe and effective in people aged 65 years and older as in younger individuals, new research suggests.
Findings from a real-world observational study of 50 older adults with type 2 diabetes were recently presented at the International Diabetes Federation (IDF) Congress 2019. With SGLT2 inhibitor treatment, average A1c level dropped from 8.5% to 7.3% (P < .01), body weight was reduced from 91.0 kg to 84.7 kg (P < .01), systolic blood pressure from 134.5 mmHg to 130.4 mmHg (P = .02), and diastolic blood pressure from 76.2 mmHg to 73.3 mmHg (P = .04).